Vaccinating livestock and poultry for the H5 series of avian influenza viruses does not have support from the entire ag sector. Friday, Zoetis announced USDA issued a conditional license for it’s killed virus-derived vaccine labeled for use in chickens.

Zoetis today announced that the U.S. Department of Agriculture (USDA), Center for Veterinary Biologics (CVB) has issued the company a conditional license for its Avian Influenza Vaccine, H5N2 Subtype,

Zoetis on Feb. 14 received a conditional license from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus.

Butter themed license plates? Listeria outbreak in nursing homes? $20M in frozen farmer funds released? Check out these headlines and more.

There is new hope when it comes to egg prices. A company producing a bird flu vaccine has now been granted conditional approval from the United States Department of Agriculture. While this current strain of the avian flu has been top of mind for the past few months,

A New Jersey pharmaceutical company has received a “a conditional license" for its bird flu vaccine for use in chickens. An infectious diseases expert comments.

Turkey’s ramped-up exports come as avian flu has killed more than 140 million egg-laying birds in the United States since 2022, and 17 million alone in November and December. Fewer birds means fewer eggs — and higher prices.

Zoetis was granted a conditional license for its avian influenza vaccine for use in chickens. It's a step closer to fighting the bird flu outbreaks that continue to devastate flocks.

Zoetis CEO Kristin Peck joins 'Closing Bell Overtime' to talk its Avian Flu vaccine, the impact of tariffs, and more.

As Bird Flu Outbreak Worsens, Zoetis Gets Green Light for Poultry Vaccine By India Edwards HealthDay Reporter TUESDAY, Feb. 18, 2025 (HealthDay News) -- The U.S. Department of Agriculture (USDA) has granted conditional approval for a new bird flu vaccine ...